Most of you know that PCYC was acquired for $261.25 in 2015. But you might not know that their stock dropped to $0.55 after clinical setback and company reorganization in 2008. Three months later the stock doubled to $1.05 on positive trial data, which led to partnership with J&J. The rest is history.

B-UP just annouced positive data. B-OM and P should have top-line data in 3-4 months. I'm not saying IPIX is PCYC right now, but I do believe IPIX has higher potential. One partnership will change the company and they have multiple shots on goal. Hang in there guys.